Y-mAbs Therapeutics, Inc.

Invesco Ltd.

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/13/2025

Shares

42,833

Value ($000)

193

Weight

0.0%

2020 Q2 - 2025 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/13/2025	193	0.0%	42,833	6/30/2025
2025 Q1	5/12/2025	144	0.0%	32,547	3/31/2025
2024 Q4	2/13/2025	117	0.0%	14,923	12/31/2024
2024 Q3	11/12/2024	191	0.0%	14,556	9/30/2024
2024 Q2	8/13/2024	172	0.0%	14,227	6/30/2024
2024 Q1	5/14/2024	216	0.0%	13,288	3/31/2024
2023 Q4	2/13/2024	90	0.0%	13,261	12/31/2023
2023 Q3	11/13/2023	64	0.0%	11,784	9/30/2023
2023 Q2	8/11/2023	80	0.0%	11,784	6/30/2023
2023 Q1	5/12/2023	68	0.0%	13,530	3/31/2023
2022 Q4	2/13/2023	70	0.0%	14,349	12/31/2022
2022 Q3	11/14/2022	242	0.0%	16,803	9/30/2022
2022 Q2	8/15/2022	1,745	0.0%	115,302	6/30/2022
2022 Q1	5/16/2022	180	0.0%	15,144	3/31/2022
2021 Q4	2/14/2022	244	0.0%	15,033	12/31/2021
2021 Q3	11/15/2021	469	0.0%	16,429	9/30/2021
2021 Q2	8/17/2021	468	0.0%	13,866	6/30/2021
2021 Q1	5/17/2021	257	0.0%	8,503	3/31/2021
2020 Q4	2/16/2021	314	0.0%	6,334	12/31/2020
2020 Q2	8/14/2020	3,674	0.0%	85,061	6/30/2020